These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 33793360)
21. [A case of intraocular malignant lymphoma diagnosed by immunoglobulin gene rearrangement and translocation, and IL-10/IL-6 ratio in the vitreous fluid]. Yokota M; Takase H; Imai Y; Kamoi K; Sugita S; Morita H; Takizawa T; Tanaka S; Shen DF; Chan CC; Mochizuki M Nippon Ganka Gakkai Zasshi; 2003 May; 107(5):287-91. PubMed ID: 12784729 [TBL] [Abstract][Full Text] [Related]
22. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center. Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738 [No Abstract] [Full Text] [Related]
23. Diagnostic potential of vitreoretinal lymphoma by detection of gene mutations with NGS in 25 Chinese patients. Chen K; Qin H; Li X; Zhou X; Ma J; Guan M Clin Chim Acta; 2024 Jul; 561():119827. PubMed ID: 38909978 [TBL] [Abstract][Full Text] [Related]
24. Vitreoretinal large B- cell lymphoma (VR- LBCL): Clinical and pathological features and treatment outcomes. Fadlelseed H; Rhatigan M; Treacy M; Murphy C; O'Neill J; Kilmartin D; Kennedy S Pathol Res Pract; 2024 Sep; 261():155500. PubMed ID: 39106590 [TBL] [Abstract][Full Text] [Related]
25. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives. Kaburaki T; Taoka K Jpn J Ophthalmol; 2023 Jul; 67(4):363-381. PubMed ID: 37209195 [TBL] [Abstract][Full Text] [Related]
26. Logistic Regression Classification of Primary Vitreoretinal Lymphoma versus Uveitis by Interleukin 6 and Interleukin 10 Levels. Kuo DE; Wei MM; Knickelbein JE; Armbrust KR; Yeung IYL; Lee AY; Chan CC; Sen HN Ophthalmology; 2020 Jul; 127(7):956-962. PubMed ID: 32197914 [TBL] [Abstract][Full Text] [Related]
27. Spontaneous regression of secondary vitreoretinal lymphoma after diagnostic vitrectomy: case report. Gan L; Ye J BMC Ophthalmol; 2023 May; 23(1):222. PubMed ID: 37198561 [TBL] [Abstract][Full Text] [Related]
28. Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma. Wang Y; Shen D; Wang VM; Sen HN; Chan CC Int J Mol Sci; 2011; 12(9):5684-97. PubMed ID: 22016619 [TBL] [Abstract][Full Text] [Related]
29. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies. Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793 [TBL] [Abstract][Full Text] [Related]
30. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma. Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124 [TBL] [Abstract][Full Text] [Related]
31. Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid Biopsy. Balikov DA; Hu K; Liu CJ; Betz BL; Chinnaiyan AM; Devisetty LV; Venneti S; Tomlins SA; Cani AK; Rao RC Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576156 [TBL] [Abstract][Full Text] [Related]
32. Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma. Carbonell D; Mahajan S; Chee SP; Sobolewska B; Agrawal R; Bülow T; Gupta V; Jones NP; Accorinti M; Agarwal M; Batchelor T; Biswas J; Cimino L; tenDam-van Loon NH; de-la-Torre A; Frenkel S; Pe'er J; Kramer M; Miserocchi E; Mochizuki M; Ness T; Rosenbaum JT; Sen HN; Simion M; Sitter H; Vasconcelos-Santos DV; Habot-Wilner Z; Coupland SE; Pulido JS; Smith J; Thorne JE; Zierhut M; Ocul Immunol Inflamm; 2021 Apr; 29(3):507-520. PubMed ID: 34009095 [TBL] [Abstract][Full Text] [Related]
34. Cell-Free DNA Extraction of Vitreous and Aqueous Humor Specimens for Diagnosis and Monitoring of Vitreoretinal Lymphoma. Brown NA; Rao RC; Betz BL J Vis Exp; 2024 Jan; (203):. PubMed ID: 38284545 [TBL] [Abstract][Full Text] [Related]
35. Challenges in the diagnosis and management of vitreoretinal lymphoma - Clinical and basic approaches. Takase H; Arai A; Iwasaki Y; Imai A; Nagao T; Kawagishi M; Ishida T; Mochizuki M Prog Retin Eye Res; 2022 Sep; 90():101053. PubMed ID: 35210172 [TBL] [Abstract][Full Text] [Related]
36. Vitreous proteomics, a gateway to improved understanding and stratification of diverse uveitis aetiologies. Schrijver B; Kolijn PM; Ten Berge JCEM; Nagtzaam NMA; van Rijswijk ALCT; Swagemakers SMA; van der Spek PJ; Missotten TOAR; van Velthoven MEJ; de Hoog J; van Hagen PM; Langerak AW; Dik WA Acta Ophthalmol; 2022 Jun; 100(4):403-413. PubMed ID: 34318583 [TBL] [Abstract][Full Text] [Related]
37. A pilot study of the use of dynamic analysis of cell-free DNA from aqueous humor and vitreous fluid for the diagnosis and treatment monitoring of vitreoretinal lymphomas. Wang X; Su W; Gao Y; Feng Y; Wang X; Chen X; Hu Y; Ma Y; Ou Q; Liang D; Huang H Haematologica; 2022 Sep; 107(9):2154-2162. PubMed ID: 35142151 [TBL] [Abstract][Full Text] [Related]
38. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Whitcup SM; Stark-Vancs V; Wittes RE; Solomon D; Podgor MJ; Nussenblatt RB; Chan CC Arch Ophthalmol; 1997 Sep; 115(9):1157-60. PubMed ID: 9298057 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma. Chen X; Hu Y; Su W; Yang S; Wang X; Zhang P; Hong X; Liang C; Qian Z; Li Z; Tao Y; Huang H; Liang D Cancer Commun (Lond); 2022 Nov; 42(11):1217-1221. PubMed ID: 35920016 [No Abstract] [Full Text] [Related]